title: Rituximab for allo-SCT-associated thrombotic thrombocytopenic purpura.
authors.forename: A M
authors.initials: AM
authors.lastname: Carella
authors.forename: G
authors.initials: G
authors.lastname: D'Arena
authors.forename: M M
authors.initials: MM
authors.lastname: Greco
authors.forename: M
authors.initials: M
authors.lastname: Nobile
authors.forename: N
authors.initials: N
authors.lastname: Cascavilla
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods; D006801:Humans; D008875:Middle Aged; D010976:Platelet Count; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy* / Q000209:etiology; D000069283:Rituximab; D014184:Transplantation, Homologous / Q000009:adverse effects*
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab